Healthcare provider profile · identity verified

Patrick Punchuk Lo, DO

Osteopathic Manipulative Medicine · OKLAHOMA CITY, OK · NPI 1295742039

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	906	278
Amlodipine Besylate	Amlodipine Besylate	681	211
Metformin Hcl	Metformin Hcl	507	157
Losartan Potassium	Losartan Potassium	471	128
Lisinopril	Lisinopril	392	103
Hydrochlorothiazide	Hydrochlorothiazide	386	114
Pravastatin Sodium	Pravastatin Sodium	349	101
Pantoprazole Sodium	Pantoprazole Sodium	323	86
Omeprazole	Omeprazole	317	93
Tamsulosin Hcl	Tamsulosin Hcl	311	99
Gabapentin	Gabapentin	287	84
Simvastatin	Simvastatin	258	84
Metoprolol Succinate	Metoprolol Succinate	231	67
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	215	68
Carvedilol	Carvedilol	195	68
Levothyroxine Sodium	Levothyroxine Sodium	191	61
Alendronate Sodium	Alendronate Sodium	187	42
Fluticasone Propionate	Fluticasone Propionate	184	74
Meloxicam	Meloxicam	178	59
Glipizide Er	Glipizide	176	59
Potassium Chloride	Potassium Chloride	172	40
Furosemide	Furosemide	169	39
Albuterol Sulfate Hfa	Albuterol Sulfate	160	47
Jardiance	Empagliflozin	157	40
Baclofen	Baclofen	142	32
Ezetimibe	Ezetimibe	133	37
Metformin Hcl Er	Metformin Hcl	126	35
Spiriva Respimat	Tiotropium Bromide	125	31
Montelukast Sodium	Montelukast Sodium	119	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	113	30
Duloxetine Hcl	Duloxetine Hcl	107	20
Metoprolol Tartrate	Metoprolol Tartrate	103	33
Finasteride	Finasteride	102	31
Ibuprofen	Ibuprofen	96	23
Pioglitazone Hcl	Pioglitazone Hcl	96	32
Triamcinolone Acetonide	Triamcinolone Acetonide	95	27
Januvia	Sitagliptin Phosphate	85	20
Eliquis	Apixaban	84	20
Raloxifene Hcl	Raloxifene Hcl	83	22
Clopidogrel	Clopidogrel Bisulfate	81	22
Rosuvastatin Calcium	Rosuvastatin Calcium	81	24
Glipizide	Glipizide	77	26
Pregabalin	Pregabalin	73	12
Synthroid	Levothyroxine Sodium	73	12
Tramadol Hcl	Tramadol Hcl	72	14
Famotidine	Famotidine	70	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	14
Sertraline Hcl	Sertraline Hcl	68	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	13
Memantine Hcl	Memantine Hcl	67	20
Glyxambi	Empagliflozin/Linagliptin	63	12
Meclizine Hcl	Meclizine Hcl	62	14
Allopurinol	Allopurinol	60	18
Celecoxib	Celecoxib	56	20
Levofloxacin	Levofloxacin	55	29
Wixela Inhub	Fluticasone Propion/Salmeterol	55	13
Tradjenta	Linagliptin	53	11
Buspirone Hcl	Buspirone Hcl	50	13
Naproxen	Naproxen	48	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	47	12
Diclofenac Sodium	Diclofenac Sodium	47	12
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Cephalexin	Cephalexin	46	22
Acetaminophen-Codeine	Acetaminophen With Codeine	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	14
Amoxicillin	Amoxicillin	44	21
Oxybutynin Chloride Er	Oxybutynin Chloride	44	13
Cefdinir	Cefdinir	43	15
Ozempic	Semaglutide	43	11
Trazodone Hcl	Trazodone Hcl	42	suppressed
Mometasone Furoate	Mometasone Furoate	39	15
Doxazosin Mesylate	Doxazosin Mesylate	38	suppressed
Lovastatin	Lovastatin	38	13
Doxycycline Hyclate	Doxycycline Hyclate	37	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	23
Farxiga	Dapagliflozin Propanediol	36	suppressed
Clobetasol Propionate	Clobetasol Propionate	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Spironolactone	Spironolactone	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	11
Propranolol Hcl	Propranolol Hcl	30	suppressed
Vascepa	Icosapent Ethyl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Mupirocin	Mupirocin	27	12
Rybelsus	Semaglutide	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	16
Enalapril Maleate	Enalapril Maleate	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Telmisartan	Telmisartan	24	suppressed
Methylprednisolone	Methylprednisolone	23	20
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	22	suppressed
Ketoconazole	Ketoconazole	22	11
Lidocaine	Lidocaine	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Atenolol	Atenolol	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Etodolac	Etodolac	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Acarbose	Acarbose	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Estradiol	Estradiol	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Prednisone	Prednisone	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Nateglinide	Nateglinide	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Prolia	Denosumab	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Topiramate	Topiramate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error